ICYMI: PhRMA ’s Ubl pens op-ed on IP waiver for COVID-19 technologies

Member states of the World Trade Organization (WTO) recentlyagreed to a waiver of intellectual property (IP) protections for COVID-19 vaccines as part of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement. Included in thisunnecessary and harmful decision, countries were given six months to decide whether to expand the waiver to COVID-19 treatments and diagnostics.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Intellectual Property Vaccines Coronavirus Source Type: news